It's a rare condition in which even minimal amounts of UV radiation are deadly to the skin. Left untreated, a child will likely die before age 10. Sadly, xeroderma pigmentosum has devastated the local population of a small Guatemalan town. Dr. Bari Cunningham, associate professor of pediatric dermatology at the University of California, San Diego School of Medicine, talks with host Dr. Andrew Krakowski about a journey through the wilderness of Guatemala, where the autosomal recessive disease has cast a shadow on life in this village. But a new day may be dawning for these people, thanks to a support team that is now championing their cause.
Xeroderma Pigmentosum in the Crosshairs: A Dermatologist's Journey to Guatemala, Part 1

Transcript
Xeroderma Pigmentosum in the Crosshairs: A Dermatologist's Journey to Guatemala, Part 1
closeReady to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
It's a rare condition in which even minimal amounts of UV radiation are deadly to the skin. Left untreated, a child will likely die before age 10. Sadly, xeroderma pigmentosum has devastated the local population of a small Guatemalan town. Dr. Bari Cunningham, associate professor of pediatric dermatology at the University of California, San Diego School of Medicine, talks with host Dr. Andrew Krakowski about a journey through the wilderness of Guatemala, where the autosomal recessive disease has cast a shadow on life in this village. But a new day may be dawning for these people, thanks to a support team that is now championing their cause.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
FCS and SHTG: Are We Meeting the Need?
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Episode 2 Part B: Effectively Transferring Over the CKD Patient at the Right Time
Level Up Your Skills: Tailoring Management of HF
Mode of Death in Patients With HFmrEF/HFpEF: The FINEARTS-HF Trial
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?